Ohcanbohtosat - Amanda Tufman
- Čájehuvvo 1 - 18 / 18
-
1
-
2
Hypobaric Hypoxia Causes Body Weight Reduction in Obese Subjects Dahkki Florian Lippl, Sonja Neubauer, S Schipfer, N Lichter, Amanda Tufman, Bärbel Otto, Rainald Fischer
Almmustuhtton 2010Artigo -
3
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study Dahkki Diego Kauffmann‐Guerrero, Kathrin Kahnert, Rosemarie Kiefl, Laura Sellmer, Julia Walter, Jürgen Behr, Amanda Tufman
Almmustuhtton 2021Artigo -
4
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients Dahkki Julian Taugner, Lukas Käsmann, Chukwuka Eze, Alexander Rühle, Amanda Tufman, Niels Reinmuth, Thomas Duell, Claus Belka, Farkhad Manapov
Almmustuhtton 2021Artigo -
5
Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells Dahkki Thomas Vollbrecht, Renate Stirner, Amanda Tufman, Julia Roider, Rudolf M. Huber, Johannes R. Bogner, Andreas Lechner, Carole Bourquin, Rika Draenert
Almmustuhtton 2012Artigo -
6
Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients... Dahkki Petra Hoffknecht, Amanda Tufman, Thomas Wehler, Theo Pelzer, Rainer Wiewrodt, Martin Schütz, Monika Serke, Jan Stöhlmacher-Williams, Angela Märten, Rudolf M. Huber, N Dickgreber
Almmustuhtton 2014Artigo -
7
Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice Dahkki Julia Walter, Caroline Moeller, Blerina Resuli, Diego Kauffmann‐Guerrero, Farkhad Manapov, Julien Dinkel, Jens Neumann, Julia Kovács, Christian Schneider, Rudolf M. Huber, Amanda Tufman
Almmustuhtton 2023Artigo -
8
Assessing lung cancer progression and survival with infrared spectroscopy of blood serum Dahkki Kosmas V. Kepesidis, Mircea-Gabriel Stoleriu, Nico Feiler, Lea Gigou, Frank Fleischmann, Jacqueline Aschauer, Sabine Eiselen, Ina Koch, Niels Reinmuth, Amanda Tufman, Jürgen Behr, Mihaela Žigman
Almmustuhtton 2025Artigo -
9
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation Dahkki John R. Gosney, Luis Paz‐Ares, Pasi A. Jänne, Keith M. Kerr, Natasha B. Leighl, María D. Lozano, Umberto Malapelle, Tony Mok, Brandon S. Sheffield, Amanda Tufman, Ignacio I. Wistuba, Solange Peters
Almmustuhtton 2023Artigo -
10
Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells Dahkki Sebastian Kobold, Stefanie Völk, Till S. Clauditz, Natascha Jennifer Küpper, Sarah Minner, Amanda Tufman, P Düwell, Michael Lindner, Ina Koch, Simon Heidegger, Simon Rothenfußer, Max Schnurr, Rudolf M. Huber, Waldemar Wilczak, Stefan Endres
Almmustuhtton 2013Artigo -
11
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions Dahkki Chukwuka Eze, Nina-Sophie Schmidt-Hegemann, Lino M. Sawicki, Julian Kirchner, Olarn Roengvoraphoj, Lukas Käsmann, Lena M. Mittlmeier, Wolfgang G. Kunz, Amanda Tufman, Julien Dinkel, Jens Ricke, Claus Belka, Farkhad Manapov, Marcus Unterrainer
Almmustuhtton 2021Revisão -
12
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic... Dahkki Solange Peters, Enriqueta Felip, Urania Dafni, Amanda Tufman, Matthias Gückenberger, Ruth Álvarez, Ernest Nadal, Annemarie Becker‐Commissaris, Hansjörg Vees, Miklos Pless, Alex Martínez‐Martí, Maarten Lambrecht, Nicolaus Andratschke, Zoi Tsourti, Anne‐Christine Piguet, Heidi Roschitzki‐Voser, A. Gasca-Ruchti, Johan Vansteenkiste, Rolf A. Stahel, Dirk De Ruysscher
Almmustuhtton 2020Artigo -
13
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations Dahkki Miriam Blasi, Jonas Kuon, H Lüders, Daniel Misch, Diego Kauffmann‐Guerrero, Moritz Hilbrandt, Daniel Kazdal, Roger-Fei Falkenstern-Ge, Björn Hackanson, Sebastian Dintner, Martin Faehling, Martina Kirchner, Anna‐Lena Volckmar, Hans‐Georg Kopp, Michael Allgäuer, Christian Grohé, Amanda Tufman, Martin Reck, Nikolaj Frost, Albrecht Stenzinger, Michael Thomas, Petros Christopoulos
Almmustuhtton 2024Artigo -
14
Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer Dahkki Ylia Salazar, Xiang Zheng, David Brunn, Hartmann Raifer, Felix S.R. Picard, Yajuan Zhang, H. Winter, Stefan Guenther, Andreas Weigert, Benno Weigmann, Laure Dumoutier, Jean‐Christophe Renauld, Ari Waisman, Anja Schmall, Amanda Tufman, Ludger Fink, Bernhard Brüne, Tobias Bopp, Friedrich Grimminger, Werner Seeger, Soni Savai Pullamsetti, Magdalena Huber, Rajkumar Savai
Almmustuhtton 2020Artigo -
15
Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board Dahkki Kathrin Heinrich, Lisa Miller‐Phillips, Frank Ziemann, Korbinian Hasselmann, Katharina Rühlmann, Madeleine Flach, Dorottya Biro, Michael von Bergwelt‐Baildon, Julian Walter Holch, Tobias Herold, Louisa von Baumgarten, Philipp A. Greif, Irmela Jeremias, Rachel Wuerstlein, Jozefina Casuscelli, Christine Spitzweg, Max Seidensticker, Bernhard W. Renz, Stefanie Corradini, Philipp Baumeister, Elisabetta Goni, Amanda Tufman, Andreas Jung, Jörg Kumbrink, Thomas Kirchner, Frederick Klauschen, Klaus H. Metzeler, Volker Heinemann, C. Benedikt Westphalen
Almmustuhtton 2022Revisão -
16
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program Dahkki Oliver Illini, Maximilian J. Hochmair, Hannah Fabikan, Christoph Weinlinger, Amanda Tufman, Aurélie Swalduz, Kristina Lamberg, Sayed M.S. Hashemi, Florian Huemer, Anders Vikström, Martin Wermke, Gudrun Absenger, Alfredo Addeo, Shantanu Banerji, Antonio Calles, Stephen Clarke, Massimo Di Maïo, Alice Durand, M. Duruisseaux, Malinda Itchins, Okko-Sakari Kääränien, Florian Krenn, Eckart Laack, Adrianus J. de Langen, Katja Mohorčič, Georg Pall, Antonio Passaro, G. Prager, Achim Rittmeyer, J. Rothenstein, Michael A. Schumacher, Ewald Wöll, Arschang Valipour
Almmustuhtton 2021Artigo -
17
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations Dahkki Felix Carl Saalfeld, Carina Wenzel, Petros Christopoulos, Sabine Merkelbach‐Bruse, Timm M. Reißig, Silke Laßmann, Steffen Thiel, Jan A. Stratmann, Ralf Marienfeld, Johannes Berger, Alexander Desuki, Janna-Lisa Velthaus, Diego Kauffmann‐Guerrero, Albrecht Stenzinger, Sebastian Michels, Thomas Herold, Michael Krämer, Sylvia Herold, Amanda Tufman, Sonja Loges, Jürgen Alt, Maria Joosten, Gerlinde Schmidtke-Schrezenmeier, Martin Sebastian, Susann Stephan-Falkenau, Cornelius F. Waller, Marcel Wiesweg, Jürgen Wolf, Michael Thomas, Daniela E. Aust, Martin Wermke
Almmustuhtton 2021Artigo -
18
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM) Dahkki Melanie Janning, Juliane Süptitz, Corinna Albers, Pierre Delpy, Amanda Tufman, J.-L. Velthaus-Rusik, Martin Reck, Andreas Jung, Diego Kauffmann‐Guerrero, Irina Bonzheim, Stephanie Brändlein, H-D. Hummel, Marcel Wiesweg, Hans‐Ulrich Schildhaus, Jan A. Stratmann, Martin Sebastian, J. Alt, J. Buth, Iréne Esposito, J. Berger, Lars Tögel, Felix Carl Saalfeld, Martin Wermke, Sabine Merkelbach‐Bruse, Axel M. Hillmer, Frederick Klauschen, Carsten Bokemeyer, Reinhard Buettner, Jennifer Moriatis Wolf, Sonja Loges, Ronald Simon, Guido Sauter, Alexander E. Volk, Jens Neumann, Frederick Klauschen, Wilko Weichert, Naser Kalhori, Reinhard Lüthen, Robert Stöhr, Chistoph Schubart, Heidemarie Wacker, Florian Fuchs, Nils Hartmann, Stefanie Graf, Christian Brandts, Peter J. Wild, Melanie Demes, Henning Reis, Gernot Rohde
Almmustuhtton 2022Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Cancer
Lung cancer
Oncology
Biology
Cancer research
Chemotherapy
Immunotherapy
Intensive care medicine
Pathology
Biochemistry
Chemistry
Genetics
Immunology
Metastasis
Paleontology
Radiation therapy
Adverse effect
Brain metastasis
Chemoradiotherapy
Disease
Epidermal growth factor receptor
Gene
Medical physics
Nivolumab
Overall survival
Progression-free survival
Prospective cohort study
Stage (stratigraphy)